Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2000
08/17/2000WO2000047624A1 Dihydroouabain-like factor and diagnostic and therapeutic compositions and methods
08/17/2000WO2000047622A2 Peptides with anti-angiogenic activity
08/17/2000WO2000047620A1 Cytokine-binding domain
08/17/2000WO2000047619A1 Therapeutics and diagnostics based on an il-1b mutation
08/17/2000WO2000047618A2 HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES
08/17/2000WO2000047613A1 Modified treponema pallidum outer membrane protein, its immunoassay use and immunoassay kit
08/17/2000WO2000047612A2 Structure-based screening techniques for drug discovery
08/17/2000WO2000047610A2 Method for altering undesirable immune responses to polypeptides
08/17/2000WO2000047602A1 33 human secreted proteins
08/17/2000WO2000047598A1 Method and apparatus for compound library preparation using optical modulator
08/17/2000WO2000047548A1 Improved compounds for protein binding
08/17/2000WO2000047317A1 Method for producing addressed ligand matrixes on a support
08/17/2000WO2000047236A1 Matrices for drug delivery and methods for making and using the same
08/17/2000WO2000047231A2 Novel antisense inhibition of rad51
08/17/2000WO2000047172A1 Hair growth stimulants and method for screening substance having hair growth stimulating effect
08/17/2000WO2000047109A1 Devices and methods for frequent measurement of an analyte present in a biological system
08/17/2000WO2000047104A2 Antagonists of hmg1 for treating inflammatory conditions
08/17/2000WO2000038838A8 Apparatus and methods for efficient processing of biological samples on slides
08/17/2000WO2000034781A3 Patterned binding of functionalized microspheres for optical diffraction-based biosensors
08/17/2000WO2000034317A3 Method for reducing immunogenicity of proteins
08/17/2000WO2000031524A3 Electrode system
08/17/2000WO2000031273A3 Process for oxidising terpenes
08/17/2000WO2000030590A3 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2
08/17/2000WO2000028080A3 Methods, software and apparati for identifying genomic regions harboring a gene associated with a detectable trait
08/17/2000WO2000024766A3 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
08/17/2000WO2000023463A3 Fluorescent dye binding peptides
08/17/2000WO2000018912A3 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases
08/17/2000WO2000017657A9 A flow cytometric, whole blood dendritic cell immune function assay
08/17/2000WO2000017643A9 A system for cell-based screening
08/17/2000WO2000016089A9 Signal detection techniques for the detection of analytes
08/17/2000WO2000016062A9 Methods for determining the activity of complex mixtures
08/17/2000WO2000015784A3 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same
08/17/2000WO2000015665A3 A method of producing a functional immunoglobulin superfamily protein
08/17/2000WO2000014477A9 Method and apparatus for assessing material properties of sheet-like materials
08/17/2000WO2000014230A9 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof
08/17/2000WO2000013796A9 Capillary printing systems
08/17/2000WO2000013026A9 Energy transfer dyes
08/17/2000WO2000013006A9 A capacitively readout multi-element sensor array with common-mode cancellation
08/17/2000WO2000011225A9 Method for determining prognosis of hiv infected individuals
08/17/2000WO2000010007A3 Devices and methods for analysis of non-ionic solutes
08/17/2000WO1999064594A3 Genes and gene expression products that are differentially regulated in prostate cancer
08/17/2000WO1999040226A3 Determination of a genotype of an amplification product at multiple allelic sites
08/17/2000DE19905734A1 Vorrichtung zur Untersuchung von Umweltchemikalien in Böden mittels eines dynamischen Labor-Testsystems An apparatus for investigating environmental chemicals in soil by means of a dynamic laboratory test system
08/17/2000DE19904650A1 cDNA-Sequenz eines Interaktors FANCIP1 des Fanconi-Anämie-Proteins der Komplementationsgruppe A cDNA sequence of an interactor FANCIP1 of the Fanconi anemia complementation group A protein
08/17/2000DE19902420A1 Verfahren und Vorrichtung zur Überlastprüfung von Ventilen Method and apparatus for overload test of valves
08/17/2000DE19902396A1 Process for measuring the nitrate content of drinking water uses a wavelength inducing an absorption maximum and an absorption minimum of the nitrate concentration curve
08/17/2000DE19900119A1 Verfahren und Vorrichtung zur Diagnose allergischer Symptome Method and apparatus for diagnosis of allergic symptoms
08/17/2000CA2365609A1 Devices and methods for frequent measurement of an analyte present in a biological system
08/17/2000CA2364288A1 Enzyme-linked immuno-magnetic electrochemical biosensor
08/17/2000CA2362612A1 Crystal structure of cpla2, and methods of identifying agonists and antagonists using same
08/17/2000CA2362592A1 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000CA2362586A1 Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism
08/17/2000CA2362541A1 Structure-based screening techniques for drug discovery
08/17/2000CA2362524A1 The ltr region of msrv-1 and the proteins it encodes, and probes and methods for detecting msrv-1 retrovirus
08/17/2000CA2362368A1 Method for altering undesirable immune responses to polypeptides
08/17/2000CA2362144A1 Predisposition to infection associated with intense exercise or other stress
08/17/2000CA2362109A1 Novel antisense inhibition of rad51
08/17/2000CA2362102A1 Process for determining the dye uptake of polyethylene terephthalate fibres
08/17/2000CA2362058A1 Process for quality control and standardisation of medicinal plant products
08/17/2000CA2362054A1 Intrabead screening methods and compositions
08/17/2000CA2362052A1 High throughput size-exclusive method of screening complex biological materials for affinity ligands
08/17/2000CA2361384A1 High throughput mass spectrometry
08/17/2000CA2361293A1 33 human secreted proteins
08/17/2000CA2359926A1 Antagonists of hmg1 for treating inflammatory conditions
08/17/2000CA2359800A1 Aptamers as reagents for high throughput screening
08/17/2000CA2359785A1 .beta.-secretase enzyme compositions and methods
08/17/2000CA2341348A1 Improved compounds for protein binding
08/17/2000CA2297441A1 Fusion proteins comprising carriers that can induce a dual immune response
08/16/2000EP1028320A2 Method of operating and automated, continuous and random access analytical system capable of simultaneously effecting multiple assays in plurality of liquid samples
08/16/2000EP1028319A2 Device and method for measuring HDL-cholesterol emplying precipitation on a solid-phase
08/16/2000EP1028318A1 Device for the optical measurement of the total hemoglobin concentration
08/16/2000EP1028317A1 Method of inferring three-dimensional structure of protein
08/16/2000EP1028316A2 Device for carrying out agglutination tests
08/16/2000EP1028315A2 Target specific screens and their use for discovering small organic molecular pharmacophores
08/16/2000EP1027932A2 Aspirating and mixing of liquids within a probe tip
08/16/2000EP1027896A1 Broadly reactive opsonic antibodies that react with common staphyloccoccal antigens
08/16/2000EP1027890A2 Homer a new target of treating psychiatric disorders
08/16/2000EP1027609A2 Method for determination of drugs of abuse in biological samples
08/16/2000EP1027608A2 Protein fragment complementation assays
08/16/2000EP1027607A1 Method for enhancing fluorescence
08/16/2000EP1027606A1 Elisa for interstitial cystitis and bladder cancer
08/16/2000EP1027605A1 Method for detecting cryptosporidium parvum oocysts
08/16/2000EP1027604A1 Extended dynamic range assays
08/16/2000EP1027603A2 Pharmaceutical grade ginkgo biloba
08/16/2000EP1027602A1 A method of determining the concentration of an analyte with the use of a bioelement and a device operating in accordance with the method
08/16/2000EP1027601A1 In vitro tissue testing system
08/16/2000EP1027600A2 Method for diagnosing cancer by measuring the presence of creatine kinase inhibitor
08/16/2000EP1027597A1 Method and device for determination of concentration
08/16/2000EP1027594A1 Fiber quality monitor
08/16/2000EP1027593A1 Process and device for carrying out fluorescence immunoassays
08/16/2000EP1027589A1 Device and method for the separation of human or animal cells of different densities from cellular dispersions which contain them
08/16/2000EP1027459A1 Telemedicine
08/16/2000EP1027457A1 Reagents and methods useful for detecting diseases of the breast
08/16/2000EP1027456A1 Expression profiles in adult and fetal organs
08/16/2000EP1027454A1 Characterising polypeptides
08/16/2000EP1027453A1 Method to diagnose and monitor cellular immune deficiencies
08/16/2000EP1027444A1 Reagents and methods useful for detecting diseases of the breast
08/16/2000EP1027443A2 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
08/16/2000EP1027442A1 Svph1-26 dna and polypeptides
08/16/2000EP1027441A2 Murine dna molecules encoding polypeptides having kinase functions
1 ... 3084 3085 3086 3087 3088 3089 3090 3091 3092 3093 3094 3095 3096 3097 3098 3099 3100 3101 3102 3103 3104 ... 3937